Core Viewpoint - Vison Pharmaceutical - B (02561.HK) has announced a board meeting scheduled for August 27, 2025, to consider and approve the interim results for the six months ending June 30, 2025, along with other matters [1] Summary by Category - Company Announcement - The board meeting will focus on the interim performance results for the first half of 2025 [1] - The meeting is set to take place on a Wednesday, indicating a structured approach to corporate governance [1] - Financial Reporting - The interim results will cover the period ending June 30, 2025, which is crucial for assessing the company's financial health [1] - The announcement reflects the company's commitment to transparency and timely reporting to stakeholders [1]
维昇药业－Ｂ(02561.HK)8月27日举行董事会会议考虑及通过中期业绩